Quintard, Clément
Tubbs, Emily
Jonsson, Gustav http://orcid.org/0000-0001-6692-8395
Jiao, Jie
Wang, Jun http://orcid.org/0000-0003-2801-4861
Werschler, Nicolas http://orcid.org/0000-0003-4860-8587
Laporte, Camille http://orcid.org/0000-0003-1577-3156
Pitaval, Amandine
Bah, Thierno-Sidy
Pomeranz, Gideon
Bissardon, Caroline
Kaal, Joris
Leopoldi, Alexandra
Long, David A. http://orcid.org/0000-0001-6580-3435
Blandin, Pierre
Achard, Jean-Luc
Battail, Christophe http://orcid.org/0000-0001-6849-7824
Hagelkruys, Astrid http://orcid.org/0000-0003-3015-4038
Navarro, Fabrice
Fouillet, Yves
Penninger, Josef M. http://orcid.org/0000-0002-8194-3777
Gidrol, Xavier http://orcid.org/0000-0002-4233-3749
Funding for this research was provided by:
Faculty of Medicine, University of British Columbia
Medizinische Universität Wien
Vienna Science and Technology Fund
Österreichischen Akademie der Wissenschaften
Gouvernement du Canada | Canadian Institutes of Health Research
Article History
Received: 28 July 2023
Accepted: 2 February 2024
First Online: 16 February 2024
Competing interests
: C.Q., J.-L.A. and Y.F. are the authors of the patent application US20210277349A1 (granted) describing the method for microfluidic perfusion used in this study. J.M.P. declares a conflict of interest as he is one of the authors of the patent application US20200199541A1 relating to blood vessel organoids generation. Furthermore, J.M.P. is the founder, shareholder, and chairman of the scientific advisory board of Angios Biotech, a company establishing BVOs for drug testing and vascular transplants. The remaining authors declare no competing interests.